Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease

被引:0
|
作者
Simone Mocellin
Pierluigi Pilati
Pierpaolo Da Pian
Marco Forlin
Susanna Corazzina
Carlo Riccardo Rossi
Federico Innocente
Carlo Ori
Dario Casara
Francesca Ujka
Donato Nitti
Mario Lise
机构
[1] University of Padova,Surgery Branch, Department of Oncological and Surgical Sciences
[2] University of Padova,Department of Anesthesiology and Pharmacology
[3] University of Padova,Department of Radiotherapy, Section of Nuclear Medicine
[4] University of Padova,Laboratory and Clinical Medicine
[5] Università di Padova,Clinica Chirurgica 2, Dipartimento di Scienze Oncologiche e Chirurgiche
来源
关键词
Isolated hepatic perfusion; Liver metastasis; Locoregional treatment; Pharmacokinetics; Treatment personalization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:802 / 809
页数:7
相关论文
共 50 条
  • [1] Correlation between melphalan pharmacokinetics and hepatic toxicity following hyperthermic isolated liver perfusion for unresectable metastatic disease
    Mocellin, Simone
    Pilati, Pierluigi
    Da Pian, Pierpaolo
    Forlin, Marco
    Corazzina, Susanna
    Rossi, Carlo Riccardo
    Innocente, Federico
    Ori, Carlo
    Casara, Dario
    Ujka, Francesca
    Nitti, Donato
    Lise, Mario
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 802 - 809
  • [2] Isolated liver perfusion for unresectable tumors: Correlation between drug pharmacokinetics and hepatic toxicity
    Pilati, P.
    Da Pian, R.
    Mocellin, S.
    Forlin, M.
    Corazzina, S.
    Nitti, D.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 33 - 33
  • [3] Correlation between pharmacokinetic findings and hepatic toxicity following hyperthermic isolated liver perfusion for unresectable metastatic tumors: a first step towards drug dosage personalization
    Pilati, P
    Mocellin, S
    Dapian, P
    Casara, D
    Darisi, T
    Forlin, M
    Rossi, R
    Nitti, D
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 41 - 41
  • [4] Analysis of Toxicity and Outcomes in Patients Undergoing Hyperthermic Isolated Hepatic Perfusion with Melphalan for Metastatic Melanoma to the Liver
    Golas, B. J.
    Magge, D.
    Zureikat, A. H.
    Zeh, H. J.
    Alexander, H. R.
    Libutti, S. K.
    Royal, R. E.
    Holtzman, M. P.
    Hughes, M. S.
    Turaga, K. K.
    Pappas, S. G.
    Gamblin, T.
    Bartlett, D. L.
    Pingpank, J. F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S20 - S20
  • [5] Analysis of toxicity and outcomes in patients undergoing hyperthermic isolated hepatic perfusion with melphalan for metastatic melanoma to the liver
    Golas, Benjamin
    Magge, Deepa
    Zureikat, Amer H.
    Zeh, Herbert
    Alexander, H. Richard
    Libutti, Steven K.
    Royal, Richard E.
    Hughes, Marybeth S.
    Holtzman, Matthew Peter
    Turaga, Kiran
    Pappas, Sam G.
    Gamblin, T. Clark
    Bartlett, David L.
    Pingpank, James F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [6] Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver
    Alexander, HR
    Libutti, SK
    Pingpank, JF
    Steinberg, SM
    Bartlett, DL
    Helsabeck, C
    Beresneva, T
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (17) : 6343 - 6349
  • [7] Isolated liver perfusion (IHP) for unresectable liver metastasis: leakage monitoring, pharmacokinetics and hepatic toxicity
    Casara, D.
    Mocellin, S.
    Arman, G.
    Nitti, D.
    Rossi, C. R.
    Pilati, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S188 - S188
  • [8] Hyperthermic isolated hepatic perfusion (IHP) using melphalan for patients with ocular melanoma (OM) metastatic to liver
    Alexander, R
    Libutti, SK
    Pingpank, JF
    Bartlett, DL
    Helsabeck, C
    Kranda, K
    Beresnev, T
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S18 - S18
  • [9] Hyperthermic isolated hepatic perfusion for the treatment of unresectable cancers confined to the liver
    Carroll, NM
    Alexander, HR
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (01) : 64 - 65
  • [10] Hyperthermic isolated liver perfusion with melphalan and bevacizumab
    Voron, T.
    Zinzindohoue, F.
    Journois, D.
    Herve, C.
    Ponzio, O.
    Lucas, N.
    [J]. JOURNAL OF VISCERAL SURGERY, 2013, 150 (01) : 60 - 66